-
Mashup Score: 1
Background The current prognostic models for patients with advanced urinary tract cancers were developed and validated in the chemotherapy setting. As immunotherapy has become the backbone of novel treatments, updated prognostic scores are needed. Methods A comprehensive analysis of inflammatory indexes from peripheral blood and clinical factors was planned on the entire real-world cohort of…
Source: medRxivCategories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 0Recurrent Exon-Deleting Activating Mutations in AHR Act as Drivers of Urinary Tract Cancer - 2 year(s) ago
Read it now on PracticeUpdate.com
Source: PracticeUpdateCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
Collapse all Expand all Background A variety of minimally invasive treatments are available as an alternative to transurethral resection of the prostate (TURP) for management of lower urinary tract symptoms (LUTS) in men with benign prostatic hyperplasia (BPH). However, it is unclear which treatments provide better results. Objectives Our primary objective was to assess the…
Source: www.cochranelibrary.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0
The purpose of this cross-sectional study was to compare gait characteristics and functional balance Babilities in men with LUTS secondary to benign prostatic h…
Source: SAGE JournalsCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 3
New paper draws more attention to self-management approaches for men.
Source: www.mdedge.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Dr. Guru Sonpavde on results of phase 3b STRONG trial of fixed-dose durvalumab in urinary tract carcinoma - 3 year(s) ago
The FDA recently approved a less-frequent, fixed dose of durvalumab at 1500 mg every 4 weeks for use in patients with metastatic urothelial carcinoma.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 2A review of upper urinary tract cytology performance before and after the implementation of The Paris System - 4 year(s) ago
Recent studies have investigated the application of The Paris System for Reporting Urinary Cytology (TPS) on lower urinary tract specimens and have mostly shown that TPS implementation improves perfo…
Source: American Cancer Society JournalsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
In this Review, Jackson and colleagues discuss the critical role of the urothelium in both normal urinary tract development and in congenital abnormalities of the urinary tract. Urothelial remodelling in congenital obstructive uropathy is also discussed.
Source: Nature Reviews UrologyCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 6
In this Review, Jackson and colleagues discuss the critical role of the urothelium in both normal urinary tract development and in congenital abnormalities of the urinary tract. Urothelial remodelling in congenital obstructive uropathy is also discussed.
Source: Nature Reviews UrologyCategories: Latest Headlines, UrologyTweet
Still in preprint form but #ITACA prognostic score from #SAUL study will likely change the way we classify patients with metastatic #urinarytract #cancer for #immunotherapy in its different forms. Special thanks to @cnsternberg @amerseburger @meeturoIT https://t.co/Le6n5Fpci3 https://t.co/j9fCeSsmwv